Old Drug Repurposed for Schizophrenia Could Reap Alzheimer’s Windfall
Read Time:3 Second
Bristol-Myers’ newly approved schizophrenia treatment might be coming full circle.
Launches of active exchange-traded funds are outnumbering passive ones by about three to one. The performance record isn’t great.
Workers who change jobs tend to reset their 401(k) accounts at a lower savings rate without realizing it. The drag...
Issuers are raising rates in anticipation of an $8 cap on late fees that is tied up in court.
Average Rating